4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001237334-25-000003
Director sold 3,000 shares at an average $423.21 ($1,269,630)
- Director acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
CAUSEY CHRISTOPHER · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,000 | $132.30 | $396,900 | 7,865 | D |
| 2025-09-02 | Sale : show line 2 in the form 10b5-1 | −1,000 | $419.63 | $419,630 | 6,865 | D |
| 2025-09-02 | Sale : show line 3 in the form 10b5-1 | −1,000 | $430.00 | $430,000 | 5,865 | D |
| 2025-09-02 | Sale : show line 4 in the form 10b5-1 | −1,000 | $420.00 | $420,000 | 4,865 | D |
| Open-market sales · 3,000 sh · avg $423.21 · $1,269,630 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-09-02 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option | −3,000 | $132.30 | 2027-06-28 | 3,000 | 0 | D |
Loading xslF345X05/primarydocument.xml…